Acaluxen 100 mg Capsule

Brand Name: Acaluxen

Molecule: Acalabrutinib

Strength: 100 mg

Quantity: 60 Capsules

Form: Capsule

Packaging Type: Bottle

Manufacturer/Marketed By: Everest Pharma

Country of Origin: Bangladesh

Description

Acaluxen 100 mg Capsule contains Acalabrutinib, a targeted anticancer medicine used to treat certain blood cancers. It helps slow cancer cell growth and disease progression under oncologist supervision.

Benefits

Targets cancer-causing B-cell pathways
Helps reduce tumor growth and spread
Improves progression-free survival in eligible patients
Convenient oral capsule form
Effective treatment option in modern hematologic oncology

Indications and Usage

Acaluxen 100 mg Capsule is indicated for:

Mantle Cell Lymphoma (MCL) in adults previously treated with at least one therapy
Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)

Treatment must be initiated and supervised by an oncologist.

How it Works

Acalabrutinib selectively inhibits Bruton Tyrosine Kinase (BTK) — a key enzyme required for malignant B-cell growth. By blocking BTK, the medicine disrupts cancer cell signaling and slows disease progression.

Dosage & Administration

Usual adult dose: 100 mg twice daily, or as prescribed
Swallow capsule whole with water
Take at the same times daily
Do not crush, chew, or open the capsule
Do not miss or double doses — consult your doctor
Regular blood tests and clinical monitoring required

Never self-medicate — dosing is personalized by an oncologist.

Side Effects

Common side effects may include:

Headache
Fatigue
Diarrhea
Muscle pain
Bruising or bleeding tendency

Serious side effects (seek urgent care):

Severe bleeding
Infections
Irregular heartbeat
Secondary cancers
Low blood cell counts

Warning and Precaution

Not recommended during pregnancy or breastfeeding
Avoid use in patients with severe heart or bleeding disorders unless advised
Higher risk of infections — report fever immediately
Avoid live vaccines during treatment
Inform your doctor about blood thinners or ongoing medications
Stop treatment and seek help if allergic or hypersensitivity symptoms appear

Osimertinib (Tagrisso) for Lung Cancer: What You Need to Know

Introduction Lung cancer is one of the most common and deadly cancers globally. The most common type of lung cancer is non-small

January 30, 2025

Rated 0 out of 5

0 reviews

Rated 5 out of 5

Rated 4 out of 5

Rated 3 out of 5

Rated 2 out of 5

Rated 1 out of 5

Reviews

Clear filters

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Product	Manufacturer / Marketed By	Price
Acalnib 100 mg Capsule	Hetero Healthcare	Ask for Price
Acaone 100 mg Capsule	Msn Laboratories India	Ask for Price
Acalaside 100 mg Capsule	Lucien Life Sciences	Ask for Price
Acaya 100 mg Capsule	Zydus	Ask for Price
Betatinib 100mg Capsule	Adley	Ask for Price

Call : +63 952 488 3302